Loading financial statements…
Import this data to Google Sheets with:
=jivedata("XBIO","financials")Full statements spill as a table. For one cell: =jivedata("XBIO","Revenue") or =jivedata("XBIO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
XBIO • CIK 0001534525
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Royalty Income, Nonoperating | $2,539.986 | $2,500.284 | $2,976.411 | $2,976.411 |
| Net Income (Loss) Attributable to Parent | $-4,134.578 | $-3,960.275 | $-2,680.86 | $-2,475.093 |
| Weighted Average Number of Shares Outstanding, Basic | 1,528,210 | 1,541,339 | 1,701,571 | 2,452,151 |
| Research and Development Expense | $3,494.765 | $3,288.332 | $3,065.484 | $2,743.354 |
| General and Administrative Expense | $3,560.936 | $3,416.38 | $2,745.509 | $3,158.991 |
| Operating Expenses | $7,055.701 | $6,704.712 | $5,810.993 | $5,902.345 |
| Operating Income (Loss) | $-4,515.715 | $-4,204.428 | $-2,834.582 | $-2,641.568 |
| Other Nonoperating Income (Expense) | $25.38 | $-5.708 | $5.725 | $4.077 |
| Interest Income (Expense), Net | $355.757 | $249.861 | $147.997 | $147.997 |
| Nonoperating Income (Expense) | $381.137 | $244.153 | $153.722 | $166.475 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Common Stock, Value, Issued | $1.544 | $1.545 | $2.294 | $2.346 |
| Additional Paid in Capital | $208,053.935 | $208,225.748 | $212,294.851 | $212,359.529 |
| Retained Earnings (Accumulated Deficit) | $-193,234.196 | $-197,194.471 | $-199,875.331 | $-201,261.408 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $253.734 | $253.734 | $253.734 | $253.734 |
| Treasury Stock, Common, Value | $5,281.18 | $5,281.18 | $5,281.18 | $5,281.18 |
| Stockholders' Equity Attributable to Parent | $9,795.641 | $6,007.18 | $7,395.822 | $6,073.021 |
| Liabilities and Equity | $10,605.226 | $6,901.443 | $8,363.847 | $6,967.998 |
| Other Assets, Noncurrent | $1,018.352 | $313.921 | $313.921 | $313.921 |
| Liabilities | $809.585 | $894.263 | $968.025 | $894.977 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $8,983.046 | $6,165.568 | $7,883.632 | $6,471.766 |
| Prepaid Expense and Other Assets, Current | $603.828 | $421.954 | $166.294 | $182.311 |
| Assets, Current | $9,586.874 | $6,587.522 | $8,049.926 | $6,654.077 |
| Accounts Payable, Current | $240.832 | $283.615 | $258.109 | $322.537 |
| Accounts Payable and Other Accrued Liabilities, Current | $568.753 | $610.648 | $709.916 | $572.44 |
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| Common Stock, Shares, Issued | 1,543,385 | 1,544,840 | 2,293,757 | 2,345,882 |
| Common Stock, Shares, Outstanding | 1,540,684 | 1,542,139 | 2,291,056 | 2,343,181 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $-4,134.578 | $-3,960.275 | $-2,680.86 | $-2,475.093 |
| Employee Benefits and Share-based Compensation | $283.085 | $171.814 | $64.787 | $64.787 |
| Net Cash Provided by (Used in) Operating Activities | $-4,114.219 | $-2,817.478 | $-2,286.651 | $-2,312.795 |
| Proceeds from Issuance of Common Stock | — | — | $4,004.715 | $4,004.715 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $-4,114.219 | $-2,817.478 | $1,718.064 | $1,691.92 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $8,983.046 | $6,165.568 | $7,883.632 | $10,067.211 |
| Increase (Decrease) in Accounts and Other Receivables | $47.734 | $-181.874 | $-255.66 | $-255.66 |
| Increase (Decrease) in Other Noncurrent Assets | $-48.579 | $-704.431 | $0 | $313.921 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $-263.571 | $84.678 | $73.762 | $-8.453 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $0 | $0 | $0 | $0 |